Institute for Evidence-Based Positioning in the Healthcare Sector

Politics, Science and Industry – Working Together for an Efficient Healthcare System

The German healthcare system is undergoing many changes: New regulations, advanced therapies, demographic trends, and rising costs are just a few of them. The offer of innovative treatment options on one side and the principle of contributory stability on the other side pose major challenges for all healthcare stakeholders. The positions and objectives of politics, pharmaceutical industry, payers and associations often seem to be incompatible.

Goals of the institute are an optimal cost-benefit ratio and constructive cooperation of all stakeholders in the healthcare sector. We advise you based on many years of experience – competently and independently.


Real-World Evidence in Germany: Challenges for Industry – Presentation at the World EPA Congress 2025

Can real-world data meaningfully complement drug assessment in Germany? In my presentation ‘Real-World Evidence in Germany: Challenges for Industry’ at the World EPA Congress 2025 in Amsterdam, I will highlight the regulatory hurdles, current developments and perspectives for companies. With over 25 years of experience in the field of drug legislation, gained through committee work and consultancy, I will highlight opportunities and pitfalls. The full programme is available at https://www.terrapinn.com/conference/pharma-pricing/agenda.stm


Vaccinations in focus: new chapter in Springer compendium

Vaccination is a central component of health care – but how are vaccination rates, legislation and economics evolving? In my new chapter ‘Vaccinations’ in the compendium Health Insurance and Care Insurance Management (Springer-Verlag), I examine the role of the STIKO, the legal framework and the challenges for the health care system. I also discuss the growing vaccine market and whether new evaluation methods will be needed to control costs in the future. The full online version can be found here: https://link.springer.com/referenceworkentry/10.1007/978-3-658-31244-2_31-1

What challenges are you facing?

Supporting the market introduction of a drug

Creating a foundation for evidence-based healthcare

Evaluating the cost-benefit ratio of a measure

Shaping health policy

Find me on LinkedIn und XING